Come up with a name for your new list and we'll add to it:
Mitobridge was acquired by
Astellas Venture Management on December 01, 2017.
Mitobridge, formerly known as Mitokyne, is a biotechnology company focused on mitochondria-related drug discovery and development. The company is utilizing its screening platform to identify and devel…